HHS, FDA To Conduct Review Of Abortion Drug Mifepristone Safety, REMS Requirements

( September 26, 2025, 3:30 PM EDT) -- The secretary of the U.S. Department of Health and Human Services and the commissioner of the U.S. Food and Drug Administration told attorneys general from 22 states that the government will be “conducting its own review of the evidence, including real-world outcomes and evidence, relating to the safety and efficacy of” mifepristone, one of the two drugs prescribed for medication abortions....

Attached Documents

Related Sections